1.Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. Mar 2015;65(2):87–108.
2.Perez-Herrero E, Fernandez-Medarde A. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy. European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. Jun 2015;93:52–79.
3.Zhao L, Gu A, Ji G, Zou P, Zhao P, Lu A. The association between ATM IVS 22–77 T>C and cancer risk: a meta-analysis. PloS one. 2012;7(1):e29479.
4.Reardon JT, Sancar A. Purification and characterization of Escherichia coli and human nucleotide excision repair enzyme systems. Methods in enzymology. 2006;408:189–213.
5.Smolarz B, Michalska MM, Samulak D, Romanowicz H, Wojcik L. Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer. Pathology oncology research: POR. Feb 2 2019.
6.Gerodimos CA, Chang HHY, Watanabe G, Lieber MR. Effects of DNA end configuration on XRCC4-DNA ligase IV and its stimulation of Artemis activity. The Journal of biological chemistry. Aug 25 2017;292(34):13914–13924.
7.de Bruin C, Mericq V, Andrew SF, et al. An XRCC4 splice mutation associated with severe short stature, gonadal failure, and early-onset metabolic syndrome. The Journal of clinical endocrinology and metabolism. May 2015;100(5):E789–798.
8.Rosin N, Elcioglu NH, Beleggia F, et al. Mutations in XRCC4 cause primary microcephaly, short stature and increased genomic instability. Human molecular genetics. Jul 1 2015;24(13):3708–3717.
9.Saito S, Kurosawa A, Adachi N. Mutations in XRCC4 cause primordial dwarfism without causing immunodeficiency. Journal of human genetics. Aug 2016;61(8):679–685.
10.Wen Y, Dai G, Wang L, Fu K, Zuo S. Silencing of XRCC4 increases radiosensitivity of triple-negative breast cancer cells. Bioscience reports. Mar 29 2019;39(3).
11.Hori M, Someya M, Matsumoto Y, et al. Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy. Medical molecular morphology. Mar 2017;50(1):25–33.
12.Lu J, Wang XZ, Zhang TQ, et al. Prognostic significance of XRCC4 expression in hepatocellular carcinoma. Oncotarget. Oct 20 2017;8(50):87955–87970.
13.Jiao K, Qin J, Zhao Y, Zhang H. Genetic effects of XRCC4 and ligase IV genes on human glioma. Neuroreport. Sep 28 2016;27(14):1024–1030.
14.Sharma V, Nandan A, Sharma AK, et al. Signature of genetic associations in oral cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine. Oct 2017;39(10):1010428317725923.
15.Romanowicz H, Pyziak L, Jablonski F, Brys M, Forma E, Smolarz B. Analysis of DNA Repair Genes Polymorphisms in Breast Cancer. Pathology oncology research: POR. Jan 2017;23(1):117–123.
16.Saadat M, Saadat S. Susceptibility to Breast Cancer and Intron 3 Ins/Del Genetic Polymorphism of DNA Double-Strand Break Repair Gene XRCC4. Journal of medical biochemistry. Oct 2015;34(4):409–413.
17.Chene G, Thompson SG. Methods for summarizing the risk associations of quantitative variables in epidemiologic studies in a consistent form. American journal of epidemiology. Sep 15 1996;144(6):610–621.
18.Zhou LP, Luan H, Dong XH, Jin GJ, Ma DL, Shang H. Association of functional polymorphisms of the XRCC4 gene with the risk of breast cancer: a meta-analysis. Asian Pacific journal of cancer prevention: APJCP. 2012;13(7):3431–3436.
19.Shao N, Jiang WY, Qiao D, et al. An updated meta-analysis of XRCC4 polymorphisms and cancer risk based on 31 case-control studies. Cancer biomarkers: section A of Disease markers. 2012;12(1):37–47.
20.Liu K, Jiang Y. Polymorphisms in DNA Repair Gene and Susceptibility to Glioma: A Systematic Review and Meta-Analysis Based on 33 Studies with 15 SNPs in 9 Genes. Cellular and molecular neurobiology. Mar 2017;37(2):263–274.
21.Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends in genetics: TIG. Sep 2004;20(9):439–444.
22.Yang B, Fan S, Zhi X, et al. Associations of MTHFR gene polymorphisms with hypertension and hypertension in pregnancy: a meta-analysis from 114 studies with 15411 cases and 21970 controls. PloS one. 2014;9(2):e87497.
23.Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Statistics in medicine. May 15 2005;24(9):1291–1306.
24.Xu FL, Wu X, Zhang JJ, Wang BJ, Yao J. A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia. Neuropsychiatric disease and treatment. 2018;14:153–164.
25.Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. Sep 6 2003;327(7414):557–560.
26.Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genetic epidemiology. Feb 2005;28(2):123–137.
27.Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. Sep 13 1997;315(7109):629–634.
28.Fu YP, Yu JC, Cheng TC, et al. Breast cancer risk associated with genotypic polymorphism of the nonhomologous end-joining genes: a multigenic study on cancer susceptibility. Cancer research. May 15 2003;63(10):2440–2446.
29.Garcia-Closas M, Egan KM, Newcomb PA, et al. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Human genetics. May 2006;119(4):376–388.
30.Figueroa JD, Malats N, Rothman N, et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis. Aug 2007;28(8):1788–1793.
31.Margulis V, Lin J, Yang H, Wang W, Wood CG, Wu X. Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Sep 2008;17(9):2366–2373.
32.Tseng HC, Tsai MH, Chiu CF, et al. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. Anticancer research. May-Jun 2008;28(3A):1687–1691.
33.Liu Y, Zhou K, Zhang H, et al. Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Human mutation. Mar 2008;29(3):381–389.
34.Chiu CF, Tsai MH, Tseng HC, et al. A novel single nucleotide polymorphism in XRCC4 gene is associated with oral cancer susceptibility in Taiwanese patients. Oral oncology. Sep 2008;44(9):898–902.
35.Siraj AK, Al-Rasheed M, Ibrahim M, et al. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population. Journal of endocrinological investigation. Oct 2008;31(10):893–899.
36.Tseng RC, Hsieh FJ, Shih CM, Hsu HS, Chen CY, Wang YC. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study. Cancer. Jul 1 2009;115(13):2939–2948.
37.Luedeke M, Linnert CM, Hofer MD, et al. Predisposition for TMPRSS2-ERG fusion in prostate cancer by variants in DNA repair genes. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Nov 2009;18(11):3030–3035.
38.Long XD, Ma Y, Huang YZ, et al. Genetic polymorphisms in DNA repair genes XPC, XPD, and XRCC4, and susceptibility to Helicobacter pylori infection-related gastric antrum adenocarcinoma in Guangxi population, China. Molecular carcinogenesis. Jun 2010;49(6):611–618.
39.Gomes BC, Silva SN, Azevedo AP, et al. The role of common variants of non-homologous end-joining repair genes XRCC4, LIG4 and Ku80 in thyroid cancer risk. Oncology reports. Oct 2010;24(4):1079–1085.
40.Shen M, Menashe I, Morton LM, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma in a pooled analysis of three studies. British journal of haematology. Nov 2010;151(3):239–244.
41.Rajaraman P, Hutchinson A, Wichner S, et al. DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro-oncology. Jan 2010;12(1):37–48.
42.Mandal RK, Singh V, Kapoor R, Mittal RD. Do polymorphisms in XRCC4 influence prostate cancer susceptibility in North Indian population? Biomarkers: biochemical indicators of exposure, response, and susceptibility to chemicals. May 2011;16(3):236–242.
43.Mittal RD, Gangwar R, Mandal RK, Srivastava P, Ahirwar DK. Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Molecular biology reports. Feb 2012;39(2):1667–1675.
44.Zhao P, Zou P, Zhao L, et al. Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility. BMC cancer. May 10 2013;13:234.
45.Ding Y, Li LN. Association between single nucleotide polymorphisms of X-ray repair cross-complementing protein 4 gene and development of pancreatic cancer. Genetics and molecular research: GMR. Aug 14 2015;14(3):9626–9632.
46.Shen Q, Tian Y, Li K, Jiang Q, Xue H, Yang S. Association of single nucleotide polymorphisms of DNA repair gene and susceptibility to pancreatic cancer. International journal of clinical and experimental pathology. 2015;8(3):3180–3185.
47.Su Y, Qi S, Dou C, Shuang L, Yan H. Association of LIG4 and XRCC4 gene polymorphisms with the risk of human glioma in a Chinese population. International journal of clinical and experimental pathology. 2015;8(2):2057–2062.
48.Makkoch J, Praianantathavorn K, Sopipong W, Chuaypen N, Tangkijvanich P, Payungporn S. Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection. Asian Pacific journal of cancer prevention: APJCP. 2016;17(2):591–595.
49.Yang HL, Qiao DD, Li K, et al. Association of genetic polymorphisms in PRKDC and XRCC4 with risk of ESCC in a high-incidence region of North China. Tumori. Mar-Apr 2016;102(2):131–134.
50.Guo C, Nakazawa Y, Woodbine L, et al. XRCC4 deficiency in human subjects causes a marked neurological phenotype but no overt immunodeficiency. The Journal of allergy and clinical immunology. Oct 2015;136(4):1007–1017.
51.Kalfalah F, Seggewiss S, Walter R, et al. Structural chromosome abnormalities, increased DNA strand breaks and DNA strand break repair deficiency in dermal fibroblasts from old female human donors. Aging. Feb 2015;7(2):110–122.